Stifel Reiterates Buy Rating on Alto Neuroscience (ANRO) as co on track for ph2b TRD study for ALTO-207
Go back to Stifel Reiterates Buy Rating on Alto Neuroscience (ANRO) as co on track for ph2b TRD study for ALTO-207| (NYSE: ANRO) | Delayed: 24.94 -1.45 (5.49%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $26.39 | 52 Week High | $ | |||
| Open | $26.45 | 52 Week Low | $ | |||
| Day High | $26.98 | P/E | N/A | |||
| Day Low | $24.92 | EPS | $ | |||
| Volume | 378,166 | |||||
